抗血小板与抗凝药物患者介入性脊柱与疼痛操作指南(第二版)
美国区域麻醉与疼痛医学学会等六家学会联合发布第二版指南,将介入性脊柱与疼痛操作按出血风险分为低、中、高三类,基于最新证据和药理学原理给出推荐,因缺乏大型随机研究未做推荐强度分级。
要点
- 按出血风险将脊柱与疼痛介入操作分为低、中、高三类。
- 低、中风险操作基本沿用区域麻醉抗凝指南,高风险操作需进一步评估。
- 因缺乏大型随机研究,未对推荐意见进行强度与分级。
核心结论
- 第二版指南针对抗血小板和抗凝药物患者接受介入性脊柱与疼痛操作,按出血风险分层给出循证或药理学驱动的推荐,但未进行推荐强度分级。
研究设计与样本
- 由ASRA、ESRA、AAPM、INS、NANS和WIP六家学会组成的指南委员会制定,通过广泛数据库检索获取最新证据,证据可用时基于证据、否则基于药理学原理形成推荐。
主要发现
- 委员会将介入性脊柱与疼痛操作按潜在出血风险分为低、中、高三类。
- ASRA区域麻醉抗凝指南被认为基本适用于低和中风险操作类别,但高风险类别需要进一步研究。
- 因缺乏足够设计良好的大型研究,无法提供推荐强度与分级。
关键数值与推荐
- 介入性脊柱与疼痛操作分为低、中、高三个出血风险等级。
临床怎么用
- 临床可依据本指南按操作出血风险分层管理抗血小板和抗凝药物。
- 低和中风险操作可参考ASRA区域麻醉抗凝指南,高风险操作需结合最新证据个体化决策。
局限性
- 缺乏设计良好的大型研究,无法对推荐意见进行强度与分级。
- 指南不能总是基于随机研究或汇总数据库中的大量患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The American Society of Regional Anesthesia and Pain Medicine (ASRA) 2012 survey of meeting attendees showed that existing ASRA anticoagulation guidelines for regional anesthesia were insufficient for their needs. Those surveyed agreed that procedure-specific and patient-specific factors required separate guidelines for pain and spine procedures. In response, a guidelines committee was formed. After preliminary review of published complications reports and studies, the committee stratified interventional spine and pain procedures according to potential bleeding risk: low-, intermediate-, and high-risk procedures. The ASRA regional anesthesia anticoagulation guidelines were largely deemed appropriate for the low- and intermediate-risk categories, but the high-risk category required further investigation. The first guidelines specific to interventional spine and pain procedures were published in 2015. Recent reviews evaluating bleeding complications in patients undergoing specific interventional pain procedures, the development of new regional anesthesia and acute pain guidelines, and the development of new anticoagulants and antiplatelet medications necessitate complementary updated guidelines. The authors desired coordination with the authors of the recently updated regional and acute pain anticoagulation guidelines. The latest evidence was sought through extensive database search strategies and the recommendations were evidence based when available and pharmacology driven otherwise. We could not provide strength and grading of these recommendations because there are not enough well-designed large studies concerning interventional pain procedures to support such grading. Although the guidelines could not always be based on randomized studies or on large numbers of patients from pooled databases, it is hoped that they will provide sound recommendations and the evidentiary basis for such recommendations. This publication is intended as a living document to be updated periodically with consideration of new evidence.
引用
- Narouze S, Benzon HT, Provenzano D, et al. Interventional Spine and Pain Procedures in Patients on Antiplatelet and Anticoagulant Medications (Second Edition): Guidelines From the American Society of Regional Anesthesia and Pain Medicine, the European Society of Regional Anaesthesia and Pain Therapy, the American Academy of Pain Medicine, the International Neuromodulation Society, the North American Neuromodulation Society, and the World Institute of Pain. Reg Anesth Pain Med. 2018. PMID: 29278603. doi:10.1097/AAP.0000000000000700
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。